Is gain of 1q a potential univariate negative prognostic marker for survival in medulloblastoma?
A gain of 1q provides a potential means of predicting overall survival in medulloblastoma.
CD151 is positively associated with the invasiveness of HGC, and CD151 or the combination of CD151 and integrin α3 is a novel marker for predicting the prognosis of HGC patients and may be potential therapeutic targets.